Annual Short Term Debt
$21.66 M
+$20.54 M+1837.39%
December 31, 2023
Summary
- As of February 26, 2025, PLX annual short term debt is $21.66 million, with the most recent change of +$20.54 million (+1837.39%) on December 31, 2023.
- During the last 3 years, PLX annual short term debt has fallen by -$38.27 million (-63.86%).
- PLX annual short term debt is now -63.86% below its all-time high of $59.93 million, reached on December 31, 2020.
Performance
PLX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.51 M
-$20.36 M-93.10%
September 30, 2024
Summary
- As of February 26, 2025, PLX quarterly short term debt is $1.51 million, with the most recent change of -$20.36 million (-93.10%) on September 30, 2024.
- Over the past year, PLX quarterly short term debt has dropped by -$20.00 million (-92.99%).
- PLX quarterly short term debt is now -97.48% below its all-time high of $59.93 million, reached on December 31, 2020.
Performance
PLX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
PLX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1837.4% | -93.0% |
| 3 y3 years | -63.9% | -93.0% |
| 5 y5 years | - | -93.0% |
PLX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1837.4% | -93.1% | +50.8% |
| 5 y | 5-year | -63.9% | +1837.4% | -97.5% | +50.8% |
| alltime | all time | -63.9% | >+9999.0% | -97.5% | +8770.6% |
Protalix BioTherapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.51 M(-93.1%) |
| Jun 2024 | - | $21.87 M(-0.0%) |
| Mar 2024 | - | $21.87 M(+1.0%) |
| Dec 2023 | $21.66 M(+1837.4%) | $21.66 M(+0.7%) |
| Sep 2023 | - | $21.50 M(+1606.7%) |
| Jun 2023 | - | $1.26 M(+9.7%) |
| Mar 2023 | - | $1.15 M(+2.8%) |
| Dec 2022 | $1.12 M(-7.4%) | $1.12 M(+11.8%) |
| Sep 2022 | - | $1.00 M(-7.7%) |
| Jun 2022 | - | $1.08 M(-12.9%) |
| Mar 2022 | - | $1.24 M(+3.0%) |
| Dec 2021 | $1.21 M(-98.0%) | $1.21 M(-73.0%) |
| Sep 2021 | - | $4.47 M(-92.2%) |
| Jun 2021 | - | $57.59 M(+1.5%) |
| Mar 2021 | - | $56.76 M(-5.3%) |
| Dec 2020 | $59.93 M | $59.93 M(+994.3%) |
| Sep 2020 | - | $5.48 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $5.45 M(+0.4%) |
| Mar 2020 | - | $5.43 M(-0.2%) |
| Dec 2019 | $5.44 M(-8.1%) | $5.44 M(+345.2%) |
| Sep 2019 | - | $1.22 M(-0.4%) |
| Jun 2019 | - | $1.23 M(-2.4%) |
| Mar 2019 | - | $1.26 M(-78.8%) |
| Mar 2018 | - | $5.93 M(+0.2%) |
| Dec 2017 | $5.92 M(-89.0%) | $5.92 M(+0.2%) |
| Sep 2017 | - | $5.91 M(-89.0%) |
| Dec 2016 | $53.87 M(>+9900.0%) | $53.87 M(>+9900.0%) |
| Sep 2000 | - | $22.80 K(-60.6%) |
| Jun 2000 | - | $57.80 K(0.0%) |
| Mar 2000 | - | $57.80 K(0.0%) |
| Dec 1999 | $57.80 K(+256.8%) | $57.80 K(+171.4%) |
| Sep 1999 | - | $21.30 K(+25.3%) |
| Jun 1999 | - | $17.00 K(0.0%) |
| Mar 1999 | - | $17.00 K |
| Dec 1998 | $16.20 K | - |
FAQ
- What is Protalix BioTherapeutics annual short term debt?
- What is the all time high annual short term debt for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual short term debt year-on-year change?
- What is Protalix BioTherapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly short term debt year-on-year change?
What is Protalix BioTherapeutics annual short term debt?
The current annual short term debt of PLX is $21.66 M
What is the all time high annual short term debt for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual short term debt is $59.93 M
What is Protalix BioTherapeutics annual short term debt year-on-year change?
Over the past year, PLX annual short term debt has changed by +$20.54 M (+1837.39%)
What is Protalix BioTherapeutics quarterly short term debt?
The current quarterly short term debt of PLX is $1.51 M
What is the all time high quarterly short term debt for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly short term debt is $59.93 M
What is Protalix BioTherapeutics quarterly short term debt year-on-year change?
Over the past year, PLX quarterly short term debt has changed by -$20.00 M (-92.99%)